EURO CELTIQUE has a total of 25 patent applications. Its first patent ever was published in 1996. It filed its patents most often in Poland, Czechia and Australia. Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are ORGANON IRELAND LTD, AVOSCIENCE LLC and NEURONASCENT INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Poland | 7 | |
#2 | Czechia | 5 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | African Regional Industrial Property Organization | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Brazil | 1 | |
#8 | Serbia | 1 | |
#9 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry | |
#4 | Machines | |
#5 | Micro-structure and nano-technology | |
#6 | Environmental technology | |
#7 | Packaging and shipping |
# | Name | Total Patents |
---|---|---|
#1 | Kyle Donald | 4 |
#2 | Victory Sam | 4 |
#3 | Goehring R Richard | 4 |
#4 | Oshlack Benjamin | 3 |
#5 | Sun Qun | 3 |
#6 | Palermo Philip | 2 |
#7 | Cavalla David | 2 |
#8 | Lee Gary | 2 |
#9 | Gehrig Andre | 2 |
#10 | Kaiko Robert F | 2 |
Publication | Filing date | Title |
---|---|---|
EP1395224A2 | Tamper resistant oral dosage form | |
CZ20002359A3 | Method of reducing capability of opoid analgesic to induce dependence | |
PL341309A1 | Method of preventing overdosage of opioidic preparations | |
CZ20002177A3 | Purine derivatives exhibiting phosphodiesterase inhibition activity |